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http://intl.elsevierhealth.com/journals/ijidJapanese Encephalitis in India and Nepal
The outbreak of Japanese Encephalitis (JE) in India and Nepal is continuing, according to the World Health Organization and recent
reports on ProMED mail number 20051105.3237 (http://w3.whosea.org/en/Section1226/Section2073.asp). As of 10 November 2005,
the WHO Regional Office for South East Asia (SEARO) has reported almost 6000 cases of JE in India and 2400 cases in Nepal.
In India, the northern state of Uttar Pradesh has been particularly badly affected, but there have also been a significant number of cases
in the adjoining state of Bihar. Since July 2005, there have been over 4900 cases in Uttar Pradesh, with more than 1300 deaths (ProMED
Mail archive number 20051105.3237). The first cases were reported from Gorakhpur, 250 km southeast of Lucknow, the state capital of
Uttar Pradesh. Most of the deaths have been in children under 15 years of age, many of whomwere malnourished. Dr K P Kishwaha, head
of Paediatrics at BRD College in Gorakhpur, said that over 900 children have died in Gorakhpur alone. He commented that the number of
deaths could be higher, as there are no government records about children dying in private nursing homes and in villages without
medicines (ProMED Mail archive number 20051019.3045).
By the end of September, disease rates were falling in Gorakhpur and its surroundings, and it was anticipated that the outbreak would
come to an end with the onset of winter. However at the beginning of November, there were reports that the disease had spread to new
areas, particularly in the west, and over 100 deaths were reported in Saharanpur over a two week period. Clearly the outbreak in India is
not yet over.
In Nepal, as of 6 November 2005, there were 2398 cases of Japanese Encephalitis reported including 271 deaths. Most occurred in the
Mid-western division and the Kailali district in Central division. Of 1592 samples tested in Nepal, 599 (38%) were positive for the JE virus.
The WHO is assisting the national authorities with technical support in the management of this outbreak. Insect control measures have
been intensified in India and there are plans to immunize all children aged between one and 12 years in 2006. Advice to travellers visiting
urban areas for short periods of time, is that risks are low. Anyone visiting endemic areas should avoid insect bites, particularly between
dusk and dawn, when the mosquito is most active. According to the WHO, vaccination should be considered for those intending to stay
for long periods in rural endemic regions during themain transmission season; for those whose planned activities will increase their risk;
and for all long-term expatriates. Further travel advice is available from the National Travel Health Network and Centre http://
www.nathnac.org/pro/clinical_updates/JE_india_nepal_191005.htm.P
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The Health Minister Sebastao Veloso announced that the most serious recorded outbreak of Marburg Haemorrhagic Fever is officially
over (ProMEDMail archive number 20051108.3269). No human cases have been reported in Angola since July 2005. The outbreak began in
October 2004 in the Uige Province, but was not formally identified until March 2005. In total, there were 252 confirmed cases of
infection, 227 of whom died. Note that these figures are actually lower than previous data reported by the WHO in August. The most
serious outbreak of Marburg until now was in the Democratic Republic of Congo, where 123 people died between 1998 and 2000.p
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The geographic progression of influenza A(H5N1), or avian influenza, has now been found to infect birds in not only East Asia, but also
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2 ProMED updatecontinues among both veterinary and human public health authorities, politicians, policy makers, and the public at large. As of 4
December 2005, the total number of reported human cases of influenza A(H5N1) in East Asia since December 2003 is 134, with 69 deaths,
a case-fatality rate of 51%. The most recently reported fatal case was in Indonesia, where there has been a total of 13 human cases
reported, including 8 fatal cases.
Of concern is that the relatively small number of reported cases is merely those that receive laboratory confirmation and that the true
number of cases is well above the reported total. Ultimately, the scenario that causes global concern is that there will not only be
intermittent cases in which there is a ‘‘species jump’’ from birds-to-humans, but that there will be subsequent efficient human-to-
human transmission of a novel and virulent strain of influenza A(H5N1). As the numbers of cases of human infection increase, there is, on
a probabilistic basis alone, an increase in the chance that one or more of viral strains will undergo a mutational event that will, in a
crowded environment as occurs in much of East Asia, be able to spread from person-to-person. Further mutation and selection in an
urban environment could lead to an efficiently transmitted strain. How this change would affect the virulence of the virus for humans is
speculative of course. Two recently reported cases in Thailand have been attributed to human-to-human transmission and have been
said to be mild. It is unknown, however, whether these cases were acquired as a consequence of environmental contamination with the
influenza A(H5N1) virus, which has been theorized to be a significant means of infection. Likewise, a good quality study on the
seroepidemiology in East Asia has not been done. This would be helpful to define the frequency of subclinical infection due to influenza
A(H5N1).
From a public health perspective, the transparency in the reporting of human infections due to influenza A(H5N1) in China has been
questioned, and there have been reports that have not been confirmed by the World Health Organization that there may have been on
the order of 200 such cases. Avian infection with influenza A(H5N1) has been documented in outbreaks over a broad geographic area in
China, from Xinjiang autonomous region in the extreme northwest to Hunan province, which borders Guangdong province in the
southeast.
Finally, there are yet other worries to consider were there a pandemicwith an especially virulent strain of influenza A. There are unlikely
to be sufficient trained personnel who are uninfected, including not only physicians, but nursing staff, respiratory therapists needed for
the management of ventilators, and trainedmedical technologists who would play a critical role in the determination of the diagnosis of
an individual’s respiratory illness. In addition, the possibility that Staphylococcus aureus, an established cause of life-threatening
secondary infection following influenza A infection, plays a larger role than ever before. Unfortunately, with the increase in community-
acquired infections due to methicillin-resistant strains of S. aureus (MRSA), many of which produce Panton-Valentine Leukocidin (PVL),
there is the potential for a horrible secondary invader following infection with a virulent strain of influenza A.
